Norda ASA operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Norda ASA with three other
pharmaceutical manufacturers in Europe:
sales of 9.08 million Euro [US$10.85 million]
of which 100%
was Research & Development),
Swedencare AB (publ)
(53.72 million Swedish Kronor [US$6.75 million]
Biotec Pharmacon ASA
(71.90 million Norwegian Kroner [US$9.18 million]
Norda ASA reported sales of NOK 75.81 million (US$9.68 million)
December of 2016.
increase of 95.6%
versus 2015, when the company's sales were NOK 38.76 million.
This was the third consecutive year of growth at Norda ASA.